The five-year award will fund a cross-disciplinary lab in Columbia, with collaborators from across the SEC and the National Institutes of Health.
The University of Missouri has been awarded a $42 million federal grant to launch a five-year cancer research initiative in Columbia, the largest single research award in the school's history, university officials announced Wednesday.
The grant, jointly administered through the National Institutes of Health, will fund a new cross-disciplinary lab focused on early-detection technologies for pancreatic, ovarian and colorectal cancers — three of the most lethal because they are typically caught late.
The Columbia team will collaborate with researchers at three SEC partner institutions and two NIH-affiliated centers, with shared data infrastructure that university leaders said could accelerate translational work by several years.
Mizzou's chancellor said the award reinforces the university's strategy of building research scale around its medical school and the MU Health Care system, which together have added more than 700 research staff since 2020.
Hiring for the new lab is expected to begin this summer, with construction on a dedicated wing of the existing health-sciences complex slated to start in the fall. The first clinical pilots are projected for 2027.
A decade in the making, the proposal would link downtown to the Mississippi with new parks, transit and a redesigned approach to the national monument.
The compromise restores funding for rural broadband and shifts hundreds of millions toward public schools and infrastructure.
The long-awaited southern extension adds sixteen stops and is projected to carry more than 8,000 daily riders by year’s end.
